Firm recognized for advising Beijing-headquartered Sinovac on funding for COVID-19 vaccine development.
Benjamin Su is a partner in the Hong Kong office of Latham & Watkins and a member of the Corporate Department.
Mr. Su represents clients on corporate and securities law matters, including US equity and debt registered offerings, Rule 144A/Regulation S equity and debt offerings, and private placements. He also has experience with PIPEs, convertible bonds, tender offers, and going private transactions. He has worked extensively across the Greater China region, particularly in the technology, financial services, renewable energy, and education sectors. He has experience advising Chinese issuers and international underwriters in capital markets transactions.